Twist Bioscience (TWST) Free Cash Flow Growth (1y) (2018 - 2026)
Analysis
Twist Bioscience (TWST) Free Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 16.06% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 69.50% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -21.08% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 56.67% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -6.83% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -5.79% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 27.54% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -4.61% |
| 10 | Twist Bioscience | 8.93 Bn | 8.76 Bn | 62.45 Mn | 18.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.14% |
| Mar 31, 2026 | -48.55% |
| Dec 31, 2025 | -46.81% |
| Sep 30, 2025 | -39.94% |
| Jun 30, 2025 | -43.88% |
| Mar 31, 2025 | 14.46% |
| Dec 31, 2024 | 3.20% |
| Sep 30, 2024 | 25.00% |
| Jun 30, 2024 | 73.70% |
| Mar 31, 2024 | 62.46% |
| Dec 31, 2023 | 62.85% |
| Sep 30, 2023 | -30.28% |
| Jun 30, 2023 | 62.66% |
| Mar 31, 2023 | 28.22% |
| Dec 31, 2022 | -10.87% |
| Sep 30, 2022 | 58.67% |
| Jun 30, 2022 | -114.22% |
| Mar 31, 2022 | -125.52% |
| Dec 31, 2021 | -108.10% |
| Sep 30, 2021 | -56.39% |